It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Metastatic spread is the mechanism in more than 90 percent of cancer deaths and current therapeutic options, such as systemic chemotherapy, are often ineffective. Here we provide a proof of principle for a novel two-pronged modality referred to as
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Department of Biomedical Engineering, Duke University, Durham, NC, USA; Department of Chemistry, Duke University, Durham, NC, USA
2 Department of Biomedical Engineering, Duke University, Durham, NC, USA
3 Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA
4 Department of Surgery, Duke University Medical Center, Durham, NC, USA
5 Department of Biomedical Engineering, Duke University, Durham, NC, USA; Department of Chemistry, Duke University, Durham, NC, USA; Fitzpatrick Institute of Photonics, Duke University, Durham, NC, USA